BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR+2.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+2.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 52.49% |
| 2024 | 659.85% |
| 2023 | 13.88% |
| 2022 | -70.35% |
| 2021 | 455.32% |
| 2020 | 46.10% |
| 2019 | 22.22% |
| 2018 | 40.18% |
| 2017 | 44.72% |
| 2016 | 16.27% |